Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Boston Scientific begins enrolment for Innova stent trial

Boston Scientific begins enrolment for Innova stent trial

7th April 2011

Boston Scientific has commenced enrolment for a clinical trial of Innova, a new stent system for treating stenosis of the superficial femoral artery or proximal popliteal artery.

The first patient for the SuperNOVA clinical study has been recruited in the US, with a total of around 300 subjects set to be enrolled at 50 sites across North America and Europe.

This trial is designed to evaluate the safety and efficacy of the self-expanding bare-metal stent system among patients with peripheral vascular lesions in arteries above the knee, with the manufacturer stating that it can deliver quality of life improvements for this group.

Boston Scientific received CE Mark approval for the Innova stent last month and plans to begin marketing the device in Europe during the second quarter of 2011.

Joe Fitzgerald, senior vice-president and president of Boston Scientific's endovascular unit, said: "The Innova stent is engineered to offer an advanced solution in treating blockages within these critical arteries."

Last month, the company announced the completion of its acquisition of Atritech, the manufacturer of the atrial fibrillation treatment device Watchman.ADNFCR-8000103-ID-800491347-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.